Skip to main content

Assessing the rate, natural history, and treatment trends of intracranial aneurysms in patients with intracranial dural arteriovenous fistulas: a Consortium for Dural Arteriovenous Fistula Outcomes Research (CONDOR) investigation.

Publication ,  Journal Article
Abecassis, IJ; Meyer, RM; Levitt, MR; Sheehan, JP; Chen, C-J; Gross, BA; Lockerman, A; Fox, WC; Brinjikji, W; Lanzino, G; Starke, RM; Chen, SH ...
Published in: J Neurosurg
April 1, 2022

OBJECTIVE: There is a reported elevated risk of cerebral aneurysms in patients with intracranial dural arteriovenous fistulas (dAVFs). However, the natural history, rate of spontaneous regression, and ideal treatment regimen are not well characterized. In this study, the authors aimed to describe the characteristics of patients with dAVFs and intracranial aneurysms and propose a classification system. METHODS: The Consortium for Dural Arteriovenous Fistula Outcomes Research (CONDOR) database from 12 centers was retrospectively reviewed. Analysis was performed to compare dAVF patients with (dAVF+ cohort) and without (dAVF-only cohort) concomitant aneurysm. Aneurysms were categorized based on location as a dAVF flow-related aneurysm (FRA) or a dAVF non-flow-related aneurysm (NFRA), with further classification as extra- or intradural. Patients with traumatic pseudoaneurysms or aneurysms with associated arteriovenous malformations were excluded from the analysis. Patient demographics, dAVF anatomical information, aneurysm information, and follow-up data were collected. RESULTS: Of the 1077 patients, 1043 were eligible for inclusion, comprising 978 (93.8%) and 65 (6.2%) in the dAVF-only and dAVF+ cohorts, respectively. There were 96 aneurysms in the dAVF+ cohort; 10 patients (1%) harbored 12 FRAs, and 55 patients (5.3%) harbored 84 NFRAs. Dural AVF+ patients had higher rates of smoking (59.3% vs 35.2%, p < 0.001) and illicit drug use (5.8% vs 1.5%, p = 0.02). Sixteen dAVF+ patients (24.6%) presented with aneurysm rupture, which represented 16.7% of the total aneurysms. One patient (1.5%) had aneurysm rupture during follow-up. Patients with dAVF+ were more likely to have a dAVF located in nonconventional locations, less likely to have arterial supply to the dAVF from external carotid artery branches, and more likely to have supply from pial branches. Rates of cortical venous drainage and Borden type distributions were comparable between cohorts. A minority (12.5%) of aneurysms were FRAs. The majority of the aneurysms underwent treatment via either endovascular (36.5%) or microsurgical (15.6%) technique. A small proportion of aneurysms managed conservatively either with or without dAVF treatment spontaneously regressed (6.2%). CONCLUSIONS: Patients with dAVF have a similar risk of harboring a concomitant intracranial aneurysm unrelated to the dAVF (5.3%) compared with the general population (approximately 2%-5%) and a rare risk (0.9%) of harboring an FRA. Only 50% of FRAs are intradural. Dural AVF+ patients have differences in dAVF angioarchitecture. A subset of dAVF+ patients harbor FRAs that may regress after dAVF treatment.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Neurosurg

DOI

EISSN

1933-0693

Publication Date

April 1, 2022

Volume

136

Issue

4

Start / End Page

971 / 980

Location

United States

Related Subject Headings

  • Retrospective Studies
  • Outcome Assessment, Health Care
  • Neurology & Neurosurgery
  • Intracranial Aneurysm
  • Humans
  • Embolization, Therapeutic
  • Central Nervous System Vascular Malformations
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Abecassis, I. J., Meyer, R. M., Levitt, M. R., Sheehan, J. P., Chen, C.-J., Gross, B. A., … CONDOR Collaborators. (2022). Assessing the rate, natural history, and treatment trends of intracranial aneurysms in patients with intracranial dural arteriovenous fistulas: a Consortium for Dural Arteriovenous Fistula Outcomes Research (CONDOR) investigation. J Neurosurg, 136(4), 971–980. https://doi.org/10.3171/2021.1.JNS202861
Abecassis, Isaac Josh, R Michael Meyer, Michael R. Levitt, Jason P. Sheehan, Ching-Jen Chen, Bradley A. Gross, Ashley Lockerman, et al. “Assessing the rate, natural history, and treatment trends of intracranial aneurysms in patients with intracranial dural arteriovenous fistulas: a Consortium for Dural Arteriovenous Fistula Outcomes Research (CONDOR) investigation.J Neurosurg 136, no. 4 (April 1, 2022): 971–80. https://doi.org/10.3171/2021.1.JNS202861.
Abecassis IJ, Meyer RM, Levitt MR, Sheehan JP, Chen C-J, Gross BA, Lockerman A, Fox WC, Brinjikji W, Lanzino G, Starke RM, Chen SH, Potgieser ARE, van Dijk JMC, Durnford A, Bulters D, Satomi J, Tada Y, Kwasnicki A, Amin-Hanjani S, Alaraj A, Samaniego EA, Hayakawa M, Derdeyn CP, Winkler E, Abla A, Lai PMR, Du R, Guniganti R, Kansagra AP, Zipfel GJ, Kim LJ, Consortium for Dural Arteriovenous Fistula Outcomes Research, CONDOR Collaborators. Assessing the rate, natural history, and treatment trends of intracranial aneurysms in patients with intracranial dural arteriovenous fistulas: a Consortium for Dural Arteriovenous Fistula Outcomes Research (CONDOR) investigation. J Neurosurg. 2022 Apr 1;136(4):971–980.

Published In

J Neurosurg

DOI

EISSN

1933-0693

Publication Date

April 1, 2022

Volume

136

Issue

4

Start / End Page

971 / 980

Location

United States

Related Subject Headings

  • Retrospective Studies
  • Outcome Assessment, Health Care
  • Neurology & Neurosurgery
  • Intracranial Aneurysm
  • Humans
  • Embolization, Therapeutic
  • Central Nervous System Vascular Malformations
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1109 Neurosciences